Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in ...
https://www.google.com/url?rct=j&sa=t&url=https://www.etfdailynews.com/2022/08/13/freeline-therapeutics-nasdaqfrln-price-target-lowered-to-5-00-at-btig-research/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw3APO4FWowOtbIxEHrnNuXc
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.